You just read:

Personal Genome Diagnostics Highlights its Patent-Pending Microsatellite Instability Testing Technology as FDA Approves Keytruda® for MSI Tumors

News provided by

Personal Genome Diagnostics Inc.

02 Jun, 2017, 07:00 ET